Neuroscience Startup BrainSightAI Raises USD750,000 In Seed Round
Bengaluru-based, BrainSightAI – a deep-tech neuroscience start-up, has raised USD750,000 in a seed round led by Stanford Angels and Entrepreneurs India, with participation from Entrepreneur First, Info Edge Ventures, and IKP Knowledge Park. Founded by Laina Emmanuel and Dr Rimjhim Agrawal, the company plans to leverage the capital to enable greater precision in diagnosing and treating neuro-oncological and neuropsychiatric disorders. “Neuro disorders, such as oncologic, trauma and psychiatric, are the third-leading contributors to the global disease burden. To be able to address these potentially life-threatening disorders better, the healthcare industry needs tools to predict outcomes earlier, discover new clinical and drug indications, and better understand drug and therapy responses. Such intuitive tools weren’t possible earlier. However, that is changing now. We are now at an inflexion point, where, with data, lots of computing power, and artificial intelligence, we can cloud-enable complex neuroscience-based workflows. Now, doctors and researchers can focus on asking questions and not on the mechanics of answering questions,” said Laina Emmanuel, Co-founder and CEO, BrainSightAI. In June 2021, the company was selected as one of the 20 start-ups from 500 applicants to the MedTech Innovator APAC 2021 Accelerator program. “BrainSight is not just improving MRI imaging, but based on Dr Rimjhim’s research at NIMHANs, leapfrogging the true potential of this modality to operate at the cutting edge of science, technology, and impact. BrainSight’s platform has the potential to change the global clinical paradigm for neurosurgery and neuropsychiatry, and we are excited to partner with Laina and Rimjhim on this journey”, commented Akshat Shah and Sandeep Singhal of Stanford Angels and Entrepreneurs India. It has also won the BIRAC BIG 15 grant from the Government of India in January 2020 for conducting clinical studies to investigate alteration in brain function in Dementia.
In June 2021, the Company was selected as one of the 20 start-ups from 500 applicants to the MedTech Innovator APAC 2021 Accelerator program.
In June 2021, the Company was selected as one of the 20 start-ups from 500 applicants to the MedTech Innovator APAC 2021 Accelerator program.
["neuroscience", "Startups"]
["Go", "API", "artificial intelligence", "programming_languages:R", "AI", "Modal", "programming_languages:Go", "RAG", "neuroscience", "Startups", "R"]
["AI", "artificial intelligence", "RAG", "R", "Go", "API", "Modal", "programming_languages:R", "programming_languages:Go"]
Kumar Gandharv, PGD in English Journalism (IIMC, Delhi), is setting out on a journey as a tech Journalist at AIM. A keen observer of National and IR-related news.